Nu-Med Plus Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-0.06	-0.07	-0.13	-0.13	-0.83	Upgrade
Depreciation & Amortization	-	-	-	0.01	0.02	Upgrade
Stock-Based Compensation	-	-	0.04	0.04	0.2	Upgrade
Other Operating Activities	-	-	-	-0.05	-0.01	Upgrade
Change in Accounts Payable	0.01	0.03	0	-0.01	0.03	Upgrade
Change in Other Net Operating Assets	0	0.03	0.02	0.11	0.38	Upgrade
Operating Cash Flow	-0.05	-0	-0.07	-0.04	-0.21	Upgrade
Short-Term Debt Issued	0.05	-	-	0.1	-	Upgrade
Total Debt Issued	0.05	-	-	0.1	-	Upgrade
Net Debt Issued (Repaid)	0.05	-	-	0.1	-	Upgrade
Issuance of Common Stock	-	-	-	-	0.03	Upgrade
Financing Cash Flow	0.05	-	-	0.1	0.03	Upgrade
Net Cash Flow	-0	-0	-0.07	0.06	-0.18	Upgrade
Free Cash Flow	-0.05	-0	-0.07	-0.04	-0.21	Upgrade
Free Cash Flow Per Share	-0.00	-	-0.00	-	-0.00	Upgrade
Levered Free Cash Flow	-0.09	0.02	-0.02	-0.18	0.12	Upgrade
Unlevered Free Cash Flow	-0.09	0.02	-0.02	-0.18	0.12	Upgrade
Change in Working Capital	0.01	0.06	0.02	0.1	0.41	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.